NCCN Guidelines for Penile Cancer 1.

2020 – Annual 9/20/19

Guideline Page Institution Vote

Panel Discussion/References
and Request YES NO ABSTAIN ABSENT
PN-4

Internal request:
Comment to consider the inclusion of Based on the discussion, the panel consensus was to include 15 0 0 11
neoadjuvant chemotherapy followed by neoadjuvant chemotherapy followed by ILND as a treatment option
ILND as a treatment option for palpable for palpable inguinal lymph nodes (unilateral, <4cm, mobile). This is
inguinal lymph nodes (unilateral, <4cm, a category 2A recommendation.
mobile).
PN-5

Internal request:
Comment to consider the inclusion of Based on the discussion, the panel consensus was to include RT as 15 0 0 11
RT as a treatment option for palpable a treatment option for palpable bulky inguinal lymph nodes. This is a
bulky inguinal lymph nodes following a category 2A recommendation.
positive percutaneous lymph node
biopsy.

Internal request:
Comment to consider the inclusion of Based on the discussion, the panel consensus was to include 15 0 0 11
chemoradiotherapy as a treatment chemoradiotherapy as a treatment option for palpable bulky inguinal
option for palpable bulky inguinal lymph lymph nodes. This is a category 2A recommendation.
nodes following a positive percutaneous
lymph node biopsy.

Page 1 of 1